A RARE KIND OF DISEASE Trademark
Trademark Overview
On Wednesday, August 23, 2000, a trademark application was filed for A RARE KIND OF DISEASE with the United States Patent and Trademark Office. The USPTO has given the A RARE KIND OF DISEASE trademark a serial number of 78022503. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, October 2, 2001. This trademark is owned by Genzyme Corporation. The A RARE KIND OF DISEASE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical Services for Genetic Diseases
General Information
| Serial Number | 78022503 |
| Word Mark | A RARE KIND OF DISEASE |
| Filing Date | Wednesday, August 23, 2000 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, October 2, 2001 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical Services for Genetic Diseases |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 8, 2000 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 1, 1999 |
| First Use In Commerce Date | Friday, October 1, 1999 |
Trademark Owner History
| Party Name | Genzyme Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Framingham, MA 017019322 |
Trademark Events
| Event Date | Event Description |
| Tuesday, October 2, 2001 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, February 12, 2001 | NON-FINAL ACTION MAILED |
| Monday, February 5, 2001 | ASSIGNED TO EXAMINER |
